← Back to catalogue

LIAISON XL MUREX HCV Ab

FDA PMA

Class II (US FDA PMA)

PMA P190011

by Diasorin Inc.

Identity

Trade Name
LIAISON XL MUREX HCV Ab; LIAISON XL MUREX Control HCV Ab FDA PMA
Generic Name
Assay, enzyme linked immunosorbent, hepatitis c virus FDA PMA

Identifiers

PMA Number
P190011 FDA PMA
FDA Product Code
MZO FDA PMA

Classification

Device Class
Class II FDA PMA
Legislation / Framework
21 CFR Part 866.3169 FDA PMA
Regulation Number
866.3169 FDA PMA
Advisory Committee
Microbiology FDA PMA
FDA Decision
APRL FDA PMA

The LIAISON XL MUREX HCV Ab Assay is an in vitro chemiluminescent immunoassay for the qualitative detection of specific antibodies to hepatitis C virus (anti-HCV) in human serum and plasma samples, including those from separator tubes. Classified as an enzyme-linked immunosorbent assay, it aids in the diagnosis of hepatitis C virus infection in adult and pediatric populations, as well as in pregnant women, though it does not determine infection status or associated disease severity.

This assay is designed for use on the LIAISON XL Analyzer and is supplied as a reagent kit for laboratory testing. It is intended for single-use and requires no sterilisation beyond manufacturer-provided packaging. The device is regulated under FDA Premarket Approval (PMA) with approval number P190011, adhering to classification MZO and regulation 866.3169. Quality control is supported by the LIAISON XL MUREX Control HCV Ab (negative and positive), validated exclusively for this assay and platform.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_PMA

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Diasorin Inc.
FDA Applicant
DiaSorin, Inc.

Sources (1)

  • FDA PMA P190011 23 fields · synced Oct 6, 2026